Veracyte, Inc.
VCYT
$32.13
$1.203.88%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 174.89% | 427.11% | 148.73% | 148.48% | 132.44% |
| Total Depreciation and Amortization | -8.71% | -4.98% | -8.02% | -11.02% | -13.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.90% | -0.53% | -35.53% | -51.41% | -49.31% |
| Change in Net Operating Assets | 89.02% | 25.92% | -5.51% | 18.23% | -403.60% |
| Cash from Operations | 81.51% | 63.70% | 85.68% | 138.92% | 69.82% |
| Capital Expenditure | 14.26% | -4.10% | 7.01% | 1.17% | -13.31% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -100.00% | -100.00% | -100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 106.63% | -- | -- | -- | -299.42% |
| Cash from Investing | 83.64% | -1,150.70% | -1,988.71% | -1,722.18% | -472.39% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -29.57% | -25.21% | 138.87% | 132.90% | 108.74% |
| Repurchase of Common Stock | -72.86% | -112.26% | -98.50% | -95.37% | -57.08% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -186.09% | -185.33% | -959.17% | -348.61% | 72.86% |
| Foreign Exchange rate Adjustments | 269.58% | 11.68% | 900.00% | -4,940.00% | -360.12% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 430.43% | -41.45% | -135.24% | -171.15% | -62.62% |